Johnson & Johnson (JNJ) EPS (Basic) Growth (5y) (2014 - 2026)
Powered by 
Analysis
Johnson & Johnson (JNJ) EPS (Basic) Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.32 Bn | 621.56 Bn | 17.26 Bn |
| 2 | AbbVie | 446.96 Bn | 440.40 Bn | 12.70 Bn |
| 3 | Merck | 357.92 Bn | 350.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.58 Bn | 259.89 Bn | 11.24 Bn |
| 5 | Pfizer | 156.78 Bn | 145.08 Bn | 10.94 Bn |
| 6 | Sanofi | 52.24 Bn | 44.86 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.93 Bn | 42.93 Bn | - |
| 8 | Incyte | 24.61 Bn | 20.07 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.84 Bn | 15.45 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | -0.73% |
| Mar 29, 2026 | -1.59% |
| Dec 28, 2025 | 26.34% |
| Sep 28, 2025 | 9.64% |
| Jun 29, 2025 | 10.81% |
| Mar 30, 2025 | 15.73% |
| Dec 29, 2024 | -1.23% |
| Sep 29, 2024 | 10.96% |
| Jun 30, 2024 | -1.63% |
| Mar 31, 2024 | -0.83% |
| Dec 31, 2023 | 7.09% |
| Oct 1, 2023 | 47.73% |
| Jul 2, 2023 | 6.08% |
| Apr 2, 2023 | -15.05% |
| Jan 1, 2023 | 17.94% |
| Oct 2, 2022 | 3.88% |
| Jul 3, 2022 | 4.55% |
| Apr 3, 2022 | 3.36% |
| Oct 3, 2021 | -2.29% |
| Jul 4, 2021 | 10.37% |